Form 4 for PCVX Vaxcyte, Inc.
Accepted 2026-06-18 20:07:40 ET · period of report 2026-06-18 · accession 0001230724-26-000010 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2026-06-18 20:07 | 2026-06-18 | PCVX | GUGGENHIME ANDREW | Pres AND CFO | M - OptEx | $5.35 | +10.0K | 114.4K | +10% | +$53.5K |
| DT | 2026-06-18 20:07 | 2026-06-18 | PCVX | GUGGENHIME ANDREW | Pres AND CFO | S - Sale+OE | $53.00 | -10.0K | 104.4K | -9% | -$530.0K |
| DT | 2026-06-18 20:07 | 2026-06-18 | PCVX | GUGGENHIME ANDREW | Pres AND CFO | M - OptEx | $0.00 | -10.0K | 236.8K | -4% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-06-18 | M | A | 10,000 | $5.35 | 114,395 | D | — | — | |
| 2 | Common | Common Stock | 2026-06-18 | S | D | 10,000 | $53.00 | 104,395 | D | — | — | (F1) The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted March 4, 2026. |
| 3 | Derivative | Stock Option (right to buy) | 2026-06-18 | M | D | 10,000 | $0.00 | 236,827 | D | $5.35 · — to 2030-05-11 | 10,000 Common Stock | (F3) Option is fully vested and exercisable. |